Braxia Scientific Ownership

BRAXF Stock  USD 0  0  33.33%   
Braxia Scientific holds a total of 240.72 Million outstanding shares. Braxia Scientific Corp shows 11.48 percent of its outstanding shares held by insiders and 0.34 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Braxia Scientific in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Braxia Scientific, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Braxia Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Braxia Pink Sheet Ownership Analysis

The company has price-to-book (P/B) ratio of 0.91. Some equities with similar Price to Book (P/B) outperform the market in the long run. Braxia Scientific Corp recorded a loss per share of 0.04. The entity had not issued any dividends in recent years. Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. Braxia Scientific Corp. is headquartered in Toronto, Ontario. Braxia Scientific operates under Biotechnology classification in the United States and is traded on OTC Exchange.The quote for Braxia Scientific Corp is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Braxia Scientific Corp please contact Roger McIntyre at 416-762-2138 or go to https://braxiascientific.com.

Braxia Scientific Outstanding Bonds

Braxia Scientific issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Braxia Scientific Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Braxia bonds can be classified according to their maturity, which is the date when Braxia Scientific Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Braxia Pink Sheet

Braxia Scientific financial ratios help investors to determine whether Braxia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Braxia with respect to the benefits of owning Braxia Scientific security.